US patent issued for the treatment of ALS with cord blood cells


Center of Excellence for Aging and Brain Repair scientists have been awarded a United States patent for their pioneering discoveries related to the treatment of ALS with umbilical cord blood cells.  “This patent, titled “Treating Amyloid Lateral Sclerosis (ALS) with Isolated Aldehyde Dehydrogenase-Positive Umbilical Cord Blood Cells” is the culmination of many years of research conducted by our research group” said Associate Professor and Inventor, Dr. Svitlana Garbuzova-Davis, Ph.D.


Svitlana Garbuzova-Davis, PhD

They are hopeful that with proper funding to spearhead required clinical trials, this new technology may someday soon help treat ALS, whereas current US FDA-approved medications only extend life span by months.

Link to patent: